NEVVI Medicare utilization intelligence

← back

HANEY, BRIANDO NPI 1285830554 Clinician

Hematology-Oncology · TOPSHAM, ME

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF NEW ENGLAND, COLLEGE OF OSTEO MEDICINE — medical school, self-reported to CMS
In practice about 20 years since medical school (class of 2006, self-reported to CMS)
Location TOPSHAM, ME · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 56 codes billed · 62,344 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
MAINE CENTER FOR CANCER MEDICINE AND BLOOD DISORDERS PA
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2026-04

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J0897 Injection, denosumab, 1 mg
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
36415 Insertion of needle into vein for collection of blood sample
J1626 Injection, granisetron hydrochloride, 100 mcg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J2469 Injection, palonosetron hcl, 25 mcg
96375 Injection of additional new drug or substance into vein
82784 Gammaglobulin (immune system protein) measurement
96413 Administration of chemotherapy into vein, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J3480 Injection, potassium chloride, per 2 meq
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
83521 Measurement of immunoglobulin light chains
82728 Ferritin (blood protein) level
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
83540 Iron level
83550 Iron binding capacity
96372 Injection of drug or substance under skin or into muscle
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J3489 Injection, zoledronic acid, 1 mg
83615 Lactate dehydrogenase (enzyme) level
84153 Psa (prostate specific antigen) measurement, total
J7030 Infusion, normal saline solution , 1000 cc
83735 Magnesium level
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
84443 Blood test, thyroid stimulating hormone (tsh)
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96360 Infusion into a vein for hydration, 31-60 minutes
96415 Administration of chemotherapy into vein, each additional hour
82607 Cyanocobalamin (vitamin b-12) level
96417 Administration of additional new drug or substance into vein, 1 hour or less
82746 Folic acid level, serum
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
85046 Red blood count automated, with additional calculations
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99442 Telephone medical discussion with physician, 11-20 minutes
96361 Infusion into a vein for hydration, each additional hour
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
36591 Collection of blood sample from implanted device
84100 Phosphate level
81000 Manual urinalysis test with examination using microscope, non-automated
G0008 Administration of influenza virus vaccine
96374 Injection of drug or substance into vein
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
90662 Influenza vaccine split virus, preservative free
90480 Admn sarscov2 vacc 1 dose
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
91320 Sarscv2 vac 30mcg trs-suc im

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.